BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9755987)

  • 1. A new preoperative immunochemotherapy for the treatment of locally advanced esophageal cancer.
    Okuno K; Tanaka A; Yoshikawa H; Shigeoka H; Jinnai H; Lee YS; Hirai N; Matsumura E; Kawai I; Yasutomi M
    Hepatogastroenterology; 1998; 45(22):950-3. PubMed ID: 9755987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathologic complete response of thoracic esophageal cancer developing after gastrectomy to neoadjuvant low-dose nedaplatin (CDGP), 5-fluorouracil and radiotherapy].
    Takemura M; Osugi H; Lee S; Nishikawa T; Fukuhara K; Iwasaki H
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1023-7. PubMed ID: 16044966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment of locally advanced squamous cell carcinoma of the esophagus by combination chemotherapy with 5-fluorouracil plus nedaplatin following tracheal stent tube placement-a case report].
    Nishimura J; Kubo N; Lee T; Shinto O; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Nagahara H; Kimura K; Amano R; Ohtani H; Yashiro M; Maeda K; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2112-4. PubMed ID: 24394030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
    Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
    J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of a 14-month survival patient on advanced esophageal cancer with uncontrolled brain metastasis completely responding to nedaplatin, adriamycin, plus 5-FU (NAF) therapy].
    Iijima S; Makari Y; Kato T; Ooshima S; Hoshi M; Doi T; Miyake Y; Sakamoto T; Kato A; Miyo M; Kurokawa E; Kikkawa N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2052-4. PubMed ID: 20037320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
    Fujita Y; Hiramatsu M; Kawai M; Sumiyoshi K; Nishimura H; Tanigawa N
    Dis Esophagus; 2008; 21(6):496-501. PubMed ID: 18840134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer.
    Miyazaki T; Ojima H; Fukuchi M; Sakai M; Sohda M; Tanaka N; Suzuki S; Ieta K; Saito K; Sano A; Yokobori T; Inose T; Nakajima M; Kato H; Kuwano H
    Ann Surg Oncol; 2015 Oct; 22(11):3653-8. PubMed ID: 25691281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Early Recurrence after Esophagectomy for Cancer Following Neoadjuvant Chemotherapy Resulting in a Complete Response of the Primary Lesion].
    Saito H; Nabeya Y; Takiguchi N; Ikeda A; Kainuma O; Soda H; Tonooka T; Arimitsu H; Yanagibashi H; Kobayashi R; Chibana T; Ishige F; Yamamoto H; Hironaka S; Nagata M
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1099-101. PubMed ID: 26469168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced esophageal cancer revealed a pathological complete response and survived more than 8 years, treated by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
    Kubo H; Nakasuga C; Tada K; Miyahara M; Hasegawa H; Kondo S; Yamashita Y
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1209-11. PubMed ID: 24047781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained complete response following combined nedaplatin+ adriamycin+5-fluorouracil therapy in a patient with superficial esophageal cancer -case report-.
    Makino T; Hirao M; Fujitani K; Takeda M; Mano M; Tsujinaka T
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1151-4. PubMed ID: 19620806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A resected case of thoracic esophageal cancer in which pCR was obtained using low-dose of nedaplatin (CDGP)/5-FU and radiotherapy].
    Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H; Higashino M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1399-402. PubMed ID: 15446565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of advanced esophageal cancer showing a long-term complete response with chemotherapy with nedaplatin alone.
    Satoh T; Tsushima K; Saitoh S; Hizawa Y; Tamura Y; Fukuda S; Yamada Y; Tohno H; Takasugi T; Sakata Y; Munakata A
    Jpn J Clin Oncol; 1999 Feb; 29(2):106-8. PubMed ID: 10089952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity data for preoperative concurrent chemoradiotherapy with oxaliplatin and continuous infusion 5-fluorouracil for locally advanced esophageal cancer.
    Thukral A; Metz J; Hwang WT; O'Dwyer P; Plastaras J; Both S; Bar-Ad V
    Dis Esophagus; 2011 Jul; 24(5):330-6. PubMed ID: 21143694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of stage IV advanced esophageal cancer with a long term survival by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
    Morimoto J; Oohira M; Kubo N; Tanaka H; Dan N; Muguruma K; Yashiro M; Sawada T; Yamashita Y; Nishiguchi Y; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2436-8. PubMed ID: 20037448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
    Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
    Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.